Legal analysis: nucleic acid testing can be reimbursed through medical insurance. On June 19, 22, the National Medical Insurance Bureau required all localities to include nucleic acid detection and other items in medical insurance according to procedures. Local governments should, on the basis of comprehensive consideration of the needs of prevention and control work in novel coronavirus, the ability of local medical insurance funds to pay and other factors, incorporate nucleic acid and antibody testing items and related consumables carried out in Covid-19 into the provincial medical insurance diagnosis and treatment project catalogue according to procedures, and simultaneously determine the payment terms.

legal basis: social insurance law of the people's Republic of China

article 2 the state establishes social insurance systems such as basic old-age insurance, basic medical insurance, industrial injury insurance, unemployment insurance and maternity insurance to protect citizens' right to get material help from the state and society in case of old age, illness, industrial injury, unemployment and maternity.

article 26 the treatment standards of basic medical insurance for employees, new rural cooperative medical care and basic medical insurance for urban residents shall be implemented in accordance with state regulations.

article 28 medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards, and emergency and rescue shall be paid from the basic medical insurance fund in accordance with state regulations.